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1. Introduction
When functions of the living kidney decrease down to under survival level, patients are
required to be treated with a system that supports kidney functions. There are several such
treatment  modalities  available,  including  peritoneal  dialysis  (PD),  hemodialysis  (HD),
hemofiltration (HF),  hemodiafiltration (HDF),  hemoadsorption (HA),  and their  advanced
derivatives, among which the most popular treatment system is HD. The artificial kidney
device  used  in  HD  is  called  “hemodialyzer”  or  more  simply  “dialyzer”  that  includes
membrane to separate the waste products and excess water from blood.
Artificial kidney is also expected to correct pH that is usually acidic before treatment by
balancing electrolytes in addition to removing waste products and excess water. All these
functions are dependent upon the permeability of the membrane used in a dialyzer and
since the quality of treatment is strongly dependent on the performance of the dialyzer,
many materials have been proposed as a candidate of the membrane. We have currently
several commercial materials available, including natural polymers and synthetic polymer‐
ic ones.
In  this  chapter,  dialysis  membrane and its  materials  are  extensively  discussed from the
physicochemical points of view, including microscopic views taken by scanning electron
microscope (SEM), mathematical expressions of membrane transport, fundamental in vitro
experiments as well as in vivo trials or clinical experiences.
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2. Basic principles and history of dialysis membrane
2.1. Law of diffusion
Dialysis is a phenomenon at which two different fluids (usually liquids) are separating flowing
on either side of the membrane (usually counter-currently) and the solute of interest in higher
concentration transports across the membrane due to concentration gradient in accordance
with the Fick’s 1-st law of diffusion, i.e.,
JAx =  - DAx
∂CA
∂ x (1)
where x is the co-ordinate in the diffusion direction [m], J Ax is the mass flux of solute A in x
direction [kg/(s m2)], D Ax is the diffusion coefficient of A in x direction [m2/s], and C A is the
concentration of A [kg/m3]. Dialysis, therefore, is one of separation techniques of the solute of
interest by using the membrane and is applied elsewhere in many industrial as well as
laboratory situations. Letting C A0 and C AL to be the concentrations of A at x=0 and x=L,
respectively (Figure 1), Eq.(1) is integrated in a straight-forward manner to get,
 J Ax =  ( DAxL )(CA0 - CAL) ≡  kM × (CA0 - CAL) (2)
where k M is the membrane permeability [m/s] defined by (D Ax/L). From Eq.(2), one would
alternately mention that the rate of diffusion is proportional to the concentration difference
between either side of the membrane. The value of k M is discussed in section 4.
x = 0 x = L
Fluid with higher
concentration, C
A0
Fluid with lower
concentration, C
AL
x x+x
JAx
Figure 1. Diffusion across a piece of membrane assuming no existence of boundary film adjacent to either side of the
membrane.
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2.2. Dawn of hemodialysis
Application of dialysis to blood purification, hemodialysis (HD), was first performed for
canines reported by Abel et al. in 1914 [1]. A chemical substance (sodium salicylate) was added
to the subject as a marker prior to the experiment, mimicking the clinical situation of kidney
failure in which waste products accumulate in the human body. Then the marker substance
was removed by the dialyzer that included the membrane made of collodion. The dialyzer
included 16 collodion tubes whose length was 40 cm that is 1.5 times longer than a currently
available normal commercial model and the diameter was about 8 mm that is approximately
40 times larger than a popular hollow fiber membrane currently utilized worldwide. Since the
collodion was too fragile to perform dialysis experiments, many other membranes cast from
natural materials were examined whether or not they were suited as a separation membrane.
Finally collodion was replaced by cellophane, and the first clinical trial was performed by Kolff
et al. in 1943 with a rotating drum dialyzer, designed and assembled by themselves [2].
Separation performance of these dialysis membranes, however, was not discussed extensively
at that time because mechanical strength of the materials was more important for performing
experiments or treatments than the permeability of the membrane.
2.3. Development of commercial dialysis membranes
Cuprophan® is a registered name of the membrane made of cuprammonium rayon made from
cellulose dissolved in cuprammonium solution, produced by Enka Co. in West Germany, later
Membrana in Polypore Co., Germany. Another cuprammonium rayon membrane with nearly
the same chemical and physical structures was developed by Asahi-Kasei Co. (Tokyo, Japan)
termed Bemberg®, followed by Terumo (Tokyo, Japan). These membranes were also called
regenerated cellulosic (RC) membrane since they were cast from cellulose or cotton fibers.
Chemical modifications were made for RC membranes mostly because of improving their
biocompatibility by replacing their hydroxyl group(s) with acetate group(s). They are called
cellulose acetate (CA), cellulose diacetate (CDA), and cellulose triacetate (CTA) in accordance
with the number of introduction of acetate groups to the cellulose backbone. Although RC
membranes are no longer commercially available, CA, CDA, and CTA membranes still have
fairly good market share since they have much higher solute and hydraulic permeabilities as
well as better biocompatibility than original RC membranes.
The first synthetic polymeric membrane was developed in 1969 by Rhône-Poulenc (France)
and was named AN-69®, since the main material of the membrane was acrylonitrile (AN). The
brand name of the dialyzer assembled with a flat sheet AN-69® membrane was RP-6® and it
was also the first dialyzer sterilized by the gamma-ray irradiation. Although the production
company of AN-69® membrane has been changed over time from Rhône-Poulenc to Hospal,
Gambro, and Baxter, dialyzers with AN-69® membrane are still available worldwide, espe‐
cially in the field of acute kidney injury (AKI) therapy since it has strong adsorption charac‐
teristic to specific substances such as inflammatory cytokines.
The first dialyzer with a cellulosic hollow fiber membrane was developed by chemical
engineers, Stuart and Lipps in 1967 [3] in Massachusetts Institute of Technology (Boston, MA,
U.S.A.), and the commercial product was available in 1972 from Cordis-Dow Co. (Miami, FL,
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U.S.A.). The basic structure of the hollow-fiber dialyzer is the same as the one of multi-tube
heat exchanger that is compact and has large surface area. Because of these advantages,
dialyzers with hollow fiber membrane have been become widely used. The first dialyzer with
a synthetic polymeric hollow fiber membrane sterilized by gamma-ray was introduced by
Toray Co. (Tokyo, Japan), in which polymethylmethacrylate (PMMA) was used as a main
material of the membrane [4].
In order to improve solute and hydraulic permeabilities as well as biocompatibilities, many
synthetic polymeric membranes have been introduced to the market since early 1980’s, and
currently these membranes are the main stream. Among them, polysulfone (PSf) and the like
(including polyethersulfone (PES), polyarylethersulfone (PAES), etc.) have the highest market
share over the world. Since these membranes are made from petroleum, they are hydrophobic
in nature. Then most of these membranes include so-called hydrophilic agent that also plays
a role of pore-forming agent when cast. The role of the hydrophilic agent is discussed later
from the chemical (section 3), mass transport (section 4), and biological (section 5) points of
view.
3. Chemical structures of dialysis membrane
3.1. Main material of the membrane
Chemical structure of the dialysis membrane usually refers to the chemical structural formula
of the main material(s) of the dialysis membrane. Most chemical structural formulae of the
main material of the membrane are tabulated in Table 1, including both natural and synthetic
polymers. Among them AN-69®, ethylenevinylalcohol (EVAL) co-polymer, polyester
polymer alloy (PEPA, Nikkiso Co., Tokyo, Japan, Figure 2) include two main materials.
Actually PMMA is also a stereo complex co-polymer of two kinds of PMMA, isotactic and
syndiotactic. Isotactic PMMA has acetate groups on only one side of the main chain, resulting
a curled structure, whereas syndiotactic PMMA has acetate groups alternately on either side
of the main chain, resulting a fairly straight structure. Combining these two polymers,
membranes with low to high hydraulic permeability has been brought to realization [4].
3.2. Hydrophilic agent
In general, cellulosic membranes are hydrophilic in nature, including original RC and its
derivatives such as CA, CDA, and CTA in which hydroxyl group(s) are replaced by acetate
group(s). On the contrary, since synthetic polymeric membranes are originated from petrole‐
um, generally speaking they are hydrophobic in nature. Blood coagulation usually occurs soon
after blood interacts with hydrophobic materials. Most synthetic polymeric membranes,
therefore, include so-called hydrophilic agent such as polyvinylpyrrolidone (PVP) to make
membrane hydrophilic. Figure 2 includes the chemical structure of PVP together with two
other polymers (polyarrylate and polyethersulfone). PEPA is composed of these two polymers
with or without PVP, the former shows little hydrophobicity, while the latter has strong
adsorptive characteristic to various proteins due to its hydrophobicity (see section 4).
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Since PVP is water-soluble, excess amount of PVP may be rinsed out from the membrane after
cast that forms pores for solute and water transport. Therefore PVP is also known as a pore-
forming agent. Namely, it should be understood that PVP residues in or on the membrane
after rinse behave as a hydrophilic agent. Both an average and a distribution of molecular
polyethersulfone（PES）
S O
O
O n
polyvinylpyrroridone（PVP）
n
CH
N
CH2
C =OH2C
CH2H2C
polyarrylate（PAR）
CH3
O C O C C
O O
CH3 n
Figure 2. Chemical structures of polyester polymer alloy (PEPA) composed of PES and PAR with polyvinylpyrrori‐
done (PVP).
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Table 1. Chemical structures of cellulosic and synthetic polymeric membranes for blood purification.
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weight of PVP are important as well as the amount of PVP used in the membrane. Moreover,
PVP may be cross-linked together and to the main material of the membrane by irradiating
gamma-ray in the final sterilization process. With this procedure, PVP should be tightly
attached together and/or on the membrane that does not allow PVP to behave as a “cushion”
(cushion effect) to the blood corpuscles [5].
Acrylic acid is specifically chosen for polyacrylonitrile (PAN, Asahi Kasei, different from
AN-69®) as a hydrophilic agent, whereas no hydrophilic agent is used in PMMA, EVAL and
the original PEPA in which micro-layer separation technology plays a significant role in casting
procedure.
4. Physical structure of dialysis membrane
4.1. Homogeneous and asymmetry membrane
Physical structures can be demonstrated in the following two ways, i.e., microscopic view
analysis and a theoretical analysis based on mathematical models. Microscopic views are
usually taken by a scanning electron microscope (SEM). Recently the microscope technology
has been advancing drastically and a field-emission SEM (FE-SEM) that has much higher
resolutions can be utilized widely.
Figure 3. A cross-sectional view of EVAL hollow fiber membrane (Asahi-Kasei, Tokyo, Japan) taken by FE-SEM.
Figure 3 is a FE-SEM of intersection of EVAL membrane (Asahi-Kasei). It is entirely a dense
membrane and the entire thickness contributes to the transport resistance for solutes and
water. Membranes of this kind are usually called “homogeneous.” Besides EVAL, PMMA, and
AN-69®, most cellulosic membranes are homogeneous. Figure 4 shows a cross-sectional view
of PSf membrane (Toray). One should realize that a dense thin layer exists on the inner surface
of the membrane, called “skin layer” from which the density is gradually decreasing in the
radial direction. Since most part excluding the skin layer is known to have little resistance for
solute and water transport, it is called the “support layer” (Figure 5). The support layer,
however, has an important role for the membrane to have enough mechanical strength with
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little resistance for transport. Membranes of this kind are called “asymmetry.” Most synthetic
polymeric membranes (except for PMMA, EVAL, and AN-69®) are asymmetry. In general,
although the physical thickness of synthetic polymeric membranes is thicker (approximately
35 μm) than that of cellulosic membranes (approximately 15 μm), the thickness that contributes
to the separation (Δx) of the former is approximately 0.5-2 μm that is much thinner than the
latter. As mentioned before, synthetic polymeric membranes are main stream these days
because much higher solute and hydraulic permeabilities are achieved with the thinner Δx.
Figure 4. A cross-sectional view of PSf hollow fiber membrane (Toray, Tokyo, Japan) taken by FE-SEM.
Figure 5. Cross-sectional views of dialysis membranes.
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4.2. Pore theory
The pore theory is often used to analyze and to design physical structures of the membrane.
The original pore theory was introduced by Pappenheimer et al. [6] to analyze the Glomerular
filtration in the living kidney (Figure 6), and was later modified by Verniory et al. [7], intro‐
ducing steric hindrance effect. Sakai [8] further modified the model by introducing the
tortuosity for transporting across the membrane. Followings are the equations for modified
pore theory.

rp
rs
rs
Separation membrane
Solute of interest
Pore
x: Membrane thickness that 
contributes to the separation [m]
Figure 6. Pore theory (pore diffusion model). Assuming pores whose radius is uniformly rp [m] with a membrane
thickness of Δx [m], through which a solute of interest whose radius is r s [m] is passing.
kM = Dw × f (q)×S D × ( Akτ × ∆ x ) (3)
L p =  ( rp28μ )× ( Akτ × ∆ x ) (4)
q =  rsrp (5)
σ =1 - g(q)×SF (6)
SD =(1 - q)2 (7)
SF =2(1 - q)2 - (1 - q)4 (8)
f (q)= 1 - 2.1050q + 2.0865q 3 - 1.7068q 5 + 0.72603q 61 - 0.75857q 5 (9)
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g(q)= 1 - (2 / 3)q 2 - 0.20217q 51 - 0.75857q 5 (10)
where k M is the membrane permeability [m/s] (see also section 1), D w is the diffusion coefficient
for the solute of interest in pure water [m2/s], A k is the surface porosity of the membrane [-],
Δx is the membrane thickness that contributes to the transport resistance [m], r s is the solute
radius [m], r p is the pore radius of the membrane [m], L p is the hydraulic permeability of the
membrane [m2 s/kg], σ is the Staverman’s reflection coefficient [-], τ is the tortuosity of the
membrane [-], q is the ratio of r s to r p [-], S D, S F, f(q), and g(q) are the dimensionless stereo
correction factors defined as functions of q. The pore theory can be applied to the situation in
which q < 0.8 is satisfied.
From Eqs.(3) and (4), it is clear that A k/(τ Δx) is an important factor both for solute and water
transport because both k M and L p include this value. Figure 7 shows two examples of L [m] x
L [m] portions of the membrane, i.e., membrane (A) with four pores with the same radius of a
[m], and membrane (B) with one pore with a radius of 2a. Then the surface porosity can be
calculated, respectively for membranes (A) and (B) with subscripts (A) and (B), i.e.,
Ak(A) =  4 × πa
2
L 2 =  
4πa 2
L 2
Ak(B) =  π(2a)
2
L 2 =  
4πa 2
L 2
∴  Ak(B)=Ak(A)
a
2a
L
L
Membrane (A) Membrane (B)
L
L
Figure 7. Portions of two modeled membranes with the same surface porosity.
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Then one would realize that membranes (A) and (B) have the same surface porosities, although
the situations are quite different in terms of the pore diameter.
Example)
Compare the two membranes (A) and (B) that have the same surface porosity (Figure 7),
tortuosity and the thickness in terms of
i. hydraulic permeability
ii. solute permeability
under the following two conditions
a. rs is negligibly small compared with a
b. rs=a/3
Solution) As stated above, A k, τ, and Δx are the same in two membranes, A k/(τ Δx) is just a
constant.
i. Recalling Eq. (4) to get,
L p(A) =  ( a 28μ )× ( Akτ × ∆ x )
L p(B) =  ( (2a)28μ )× ( Akτ × ∆ x ) =  ( 4a28μ )× ( Akτ × ∆ x )
∴  Lp(B)=4 Lp(A)
Therefore, the membrane (B) has four times higher hydraulic permeability than the membrane
(A).
ii. Since q=0 may reasonably be applied in this case, recalling Eqs.(7)-(10) to get,
SD=SF=f(q)=g(q)=1
in both membranes (A) and (B). Therefore Eq.(3) may be simplified as follows,
kM(A) =kM(B) = Dw ×(1)× (1)× ( Akτ × ∆ x )= Dw × ( Akτ × ∆ x )
Consequently, there is no difference between membranes (A) and (B) in terms of transport of
small solutes.
iii. Recalling Eq.(5),
q(A) =  
rs
rp =
a / 3
a = 13
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q(B) =  
rs
rp =
a / 3
2a = 16
Then recalling Eqs.(7) and (9) with q values calculated above,
SD(A)=(1-q(A))2=0.8889
SD(B)=(1-q(B))2=0.9722
f(q(A))=0.3707
f(q(B))=0.6587
Then from Eq.(3),
kM(A) = Dw ×(0.3707)× (0.8889)× ( Akτ × ∆ x )=0.3295× Dw × ( Akτ × ∆ x )
kM(B) = Dw ×(0.6587)× (0.9722)× ( Akτ × ∆ x )=0.6404× Dw × ( Akτ × ∆ x )
∴  kM(B)=1.94 kM(A)
Finally one would conclude that the membrane (B) has almost two times higher solute
permeability than the membrane (A) for those solutes whose r s =a/3.
Chemical characteristic determines the hydrophilicity and hydrophobicity of the material,
whereas physical structure determines the pore sizes as well as the thickness that contributes
to the transport resistance. Therefore, both chemical and physical features are important for
designing dialysis membrane.
5. Performance of dialysis membrane
In this section, we discuss the performances under in vitro ultrafiltration experiments and those
under on-line HDF in clinical situations because the former is suited for evaluation of maximal
performance of the membrane and the latter takes a responsibility of the real performance
under advanced clinical situations.
5.1. Aqueous in vitro ultrafiltration experiment
Six filters (dialyzers), one with PSf (PS-1.6UW, Fresenius-Kawasumi Co., Tokyo, Japan) and
other five with PEPA (Nikkiso Co., Tokyo, Japan) were investigated (Table 2). Since both PSf
and PEPA are hydrophobic in nature, these membranes include PVP for anti-thrombosis
purpose, except for one dialyzer that includes PEPA membrane with no additives (FLX).
Amount of PVP used in the membrane is semi-quantitatively shown as (+++), (++), (+), and (-),
respectively for “most”, “much”, “small” and “none”.
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# name ofproducts
abbreviated
names
Surface area
[m2]
membrane
materials hydrophilic agent pore size info
membrane
make
1 PS-1.6UW PS 1.6 PSf PVP (+++) (Not available)
Fresenius
Medical Care,
Badhonburg,
Germany
2 FLX-15GW FLX 1.5 PEPA PVP (-) standard Nikkiso Co.,Tokyo, Japan
3 FDX-15GW FDX 1.5 PEPA PVP (+) standard Nikkiso Co.,Tokyo, Japan
4 FDY-15GW FDY 1.5 PEPA PVP (+) larger Nikkiso Co.,Tokyo, Japan
5 FDX-150GW new FDX 1.5 PEPA PVP (++) standard Nikkiso Co.,Tokyo, Japan
6 FDY-150GW new FDY 1.5 PEPA PVP (++) larger Nikkiso Co.,Tokyo, Japan
Table 2. Technical specification of investigated ultrafilters
The time courses of the sieving coefficient (s.c. 4) [9, 10] for albumin of PS-1.6UW dialyzer were
shown in Figure 8. Strong time-dependent patterns were found with peak values approxi‐
mately at 10 minutes after starting experiments. The lower the albumin concentration, the
higher the s.c. 4 values was found with longer time for achieving steady-state.
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Figure 8. Time courses of the sieving coefficient for albumin under various concentrations of albumin in PS-1.6UW
(PSf membrane) QBi=200 mL/min, QF=10 mL/min, Volume of test sol’n=2.0 L.
The time courses of s.c. 4 for albumin of three PEPA filters with albumin concentration of 3.64
mg/mL are shown in Figure 9. The s.c. 4 gradually increased in these PEPA with PVP(-) or
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PVP(+) and never took peak values. Membranes used in FLX and FDX basically have the same
pore sizes and the only difference is that the latter contained PVP, which concludes that PVP
directly influences the membrane transport of albumin. By enlarging the pore diameter by
approximately 5 % in FDY with the same PVP content, the s.c. 4 increased with the enlargement
accordingly.
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Figure 9. Time courses of the sieving coefficient for albumin under a fixed albumin concentration (3.64 mg/mL) in
three PEPA membrane dialyzers Curves are different from the ones found with PSf membrane. QBi=200 mL/min, QF=10
mL/min, Volume of test sol’n=2.0 L.
The time courses of s.c. 4 for albumin of the latest version of PEPA dialyzers are depicted in
Figure 10 for albumin concentration of 3.64 mg/mL. It should be noted that the peak values
were found in new PEPA membranes that included increased amount of PVP at 6 minutes
after starting the experiments. Moreover, time dependent pattern of these curves are different
from the ones shown in Figure 9 and are similar to those found with PSf membrane in Figure
8. Then it may be concluded that the time course of s.c. 4 for albumin is strongly dependent on
the amount of PVP included in the membrane and not on the main material of the membrane.
Since the albumin concentrations of the test solutions were lower by the factor of 1/30-1/10 to
the standard albumin concentration in human blood (3.6 – 4.0 g/dL), s.c. 4 values for albumin
shown above do not directly correspond to the clinical results. One should, however, need to
consider that the membrane separation characteristics depend on the pore diameter, amount
of hydrophilic agent as well as experimental conditions [11].
5.2. Clinical performance of super-high flux dialyzers/diafilters
According to the Japanese reimbursement system, all the commercial dialyzers are classified
into five categories in accordance with the clearances for β2-microglobulin (β2-MG, MW 11800)
under Q B=200 mL/min, Q D=500 mL/min for dialyzers with surface area of 1.5 m2 (Table 3).
Classes IV and V dialyzers, clearances for β2-MG greater or equal to 50 and 70 mL/min,
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respectively, are the “super-high flux” models and more than 95 % of Japanese dialysis patients
are treated with dialyzers of this kind [12]. These dialyzers had been used also for on-line
hemodiafiltration (HDF) with considerable amount of albumin removal (> 3 g/treatment) until
2010 before on-line HDF has been officially announced to be included in the reimbursement
system.
reimbursement system
Class
2-MG clearance   
[mL/min]
Reimbursement
I < 10 low
II >=10～< 30
III >=30～< 50
IV >=50～< 70
V >= 70 high

1. Flow conditions: Q B=200 mL/min, Q D=500 mL/min, Q F=10 mL/min/m2.
2. A 0=1.5 m2
3. If A 0 is NOT1.5 m2, use of the closest model is recommended. Clearance for β2-MG under A 0=1.5 m2 may be estimated
by using the performance evaluation equations with K o A as a constant.
Table 3. Classification of dialyzers in Japanese reimbursement system
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Figure 10. Time courses of the sieving coefficient for albumin under a fixed albumin concentration (3.64 mg/mL) in
two new PEPA membrane dialyzers Curves are similar to the ones found with PSf membrane. QBi=200 mL/min, QF=10
mL/min, Volume of test sol’n=2.0 L.
Updates in Hemodialysis176
Although 99 uremic toxins are compiled by Vanholder [13], clinicians and researchers have
different opinions on which solutes to be removed or up to how much albumin may be leaked
out. Figure 11 shows the relationship between the reduction rate of β2-MG and albumin loss
taken with various dialyzers in different modalities. Only a limited increase in β2-MG
reduction was found with the increase of albumin removal. Therefore β2-MG removal may
not be directly related to convection transport when super-high flux dialyzers are used. In
other words, super high-flux dialyzers are the ones in which β2-MG removal does not correlate
with the amount of albumin loss or the convection transport.

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Figure 11. Relationship between the reduction rate of β2-microglobulin (MW: 11,800) and albumin loss.
Figure 12 shows the same relationship between the reduction rate of α1-microglobulin (α1-MG,
MW 33,000) and albumin loss. Up to albumin loss of 3 g/session, almost linear relationship
was observed, meaning that it may not be possible to remove α1-MG without removing
albumin, although the molecular weight of albumin is twice as large as that of α1-MG. There
is no such article that reports α1-MG is toxic; moreover, α1-MG is not even included in
Vanholder’s list [13]. We, however, experienced fairly good number of patients who have
become better with albumin loss of 3 g or more for bone pain, shoulder pain, and improvement
of fingertip power, and 5 g or more for finger numbness, restless legs syndrome. Therefore α1-
MG may be a possible surrogate marker of HDF treatment for those who have symptoms with
normal HD therapy. Relief of clinical symptoms with various treatment modalities is sum‐
marized in Figure 13.
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Figure 12. Relationship between the reduction rate of α1-microglobulin (MW: 33,000) and albumin loss.
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APS-25SA(HD QB200) APS-25SA(50L QB200)
APS-25SA(50L QB240) APS-21E(HD QB200)
APS-25SA(post12L QB200) FDY-210GW(post10L QB200)
APS-21E(50L QB200)
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Prevention of 
symptoms
Dialysis induced hypotension
(Italian study)
Figure 13. Relief of clinical symptoms by employing various protein-losing treatment modes.
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5.3. Consideration of on-line HDF
On-line HDF is mostly performed in post-dilution mode with high Q B (400 mL/min) in
European countries, whereas that is mostly performed in pre-dilution mode with limited Q B
(250 mL/min) in Japan. Diafilters preferred in post-dilution and pre-dilution HDF must be
designed under different concepts. Membrane for the post-dilution HDF requires a limited
permeability for albumin, otherwise unexpected large amount of albumin may be leaked out.
Therefore relatively large surface area is preferred for achieving large amount of fluid
exchange (20 L/session). Since usually higher clearances are expected with post-dilution HDF,
membrane for the pre-dilution HDF prefers higher solute permeability that may allow much
albumin to penetrate across the membrane. Amount of albumin loss, however, may be
relatively easily controlled by changing the amount of ultrafiltration that is usually around 60
L/session. In the recent market, since diafilters specifically designed for either post-dilution or
pre-dilution are available, choice of diafilters must be paid much attention not only for effective
treatment but also for safety. Moreover, a proposal of technical specifications for the future
diafilters is also reported [14].
Many randomized control studies have been done in order to verify superiority or better
outcomes of on-line HDF [15-[19]; however, we have not yet come into a conclusion that states
on-line HDF is better than other treatment modalities. These studies showed that on-line HDF
was at least better than low-flux HD; however, the difference between on-line HDF and high-
flux HD was ambiguous [18, 19], in terms of survival rate within a study period of three years
or so. Post–hoc analyses and sub-analyses of those studies showed superiority of on-line HDF
with large amount of fluid exchange (at least > 15 L) to other treatment modalities in terms of
dialysis-induced hypotension, reaction to ESR medications, as well as survival rate. Among
them, the ESHOL study [20] greatly encouraged patients on dialysis as well as medical staffs
in which on-line HDF showed better clinical outcomes in all the end points than high-flux HD.
Many debates, however, still continues also elsewhere including in Japan where the number
of patients on on-line HDF is rapidly growing and exceeded 10 % of the total patients [21].
6. Biological consideration of dialysis membrane
Biological consideration of the dialysis membrane is often referred to biocompatibility. Since
dialyzers are repeatedly used four hours a session, three times a week, even a small event that
repeatedly would occur each time may cause undesired side effects such as chronic inflam‐
mation.
6.1. Improvement of biocompatibility of the regenerated cellulosic membrane
Up until 1970s, RC membrane dominated over the market, and it was gradually replaced by
synthetic polymeric membranes. Transient leukopenia that is an abrupt decease of leukocytes
occurs at 15 to 30 minutes after starting the treatment has been one of the best known bio-
incompatible events [22]. Reprocessing dialyzers was common in 1970’s and since bio-
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incompatible events were often found when a dialyzer was used for the first time, this was
called the “first use syndrome” [23].
Craddock et al. reported that complement activation under the use of RC membrane induced
transient accumulation of leukocytes in the blood vessels and in the lung [24]. As shown in
section 2, RC has three hydroxyl groups in its backbone, and these hydroxyl groups have been
realized to be closely related to undesired complement activation. Then acetate groups was
introduced to the one, two, or all three of hydroxyl group(s) to produce cellulose acetate (CA),
cellulose diacetate (CDA), and cellulose triacetate (CTA), respectively. Since these semi-
synthesized cellulosic membranes have not only better biocompatibility but also higher
permeabilities for solutes and water transport, they are still on the market.
6.2. Improvement of biocompatibility of synthetic polymeric membrane
It is well known that the Glomerular basement membrane (GBM) in human kidney is nega‐
tively charged. Although AN-69® is also a negatively charged membrane, one must pay much
attention for the use of this membrane because it may cause anaphylaxy shock soon after
starting the treatment [25]. Strong negative charge (-70 mV) would activate Hageman (XII)
factor to XIIa that eventually produces bradykinin from kininogen as a substrate. Under
normal situation bradykinin may be deactivated by kininase II; however, if the patient takes
angiotensin-converting enzyme (ACE) inhibitor, it deactivates kininase II. This would induce
the cascade reaction with bradykinin, including NO generation, increased vascular permea‐
bility, expansion of blood vessels, suppressing blood pressure, and ending up with shock
during the treatment. This is often called “negative charge syndrome” (NCS, Figure 14).
Although all dialysis membranes are negatively charged, it is usually a contraindication to
prescribe ACE inhibitor to a patient under the use of AN69®.
Contact of blood to the 
negative charged  material
XII XIIa
kallikrein
deactivation
kininase II
ACE inhibitor
phospholipase
Expansion of blood vessel
Anaphylaxis syndrome
phospholipid
arachidonic acid
prostanoids
NO generation
Increased vascular 
permeability
kininogen bradykinin
Figure 14. Mechanisms of negative charge syndrome (NCS).
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6.3. Surface improvement technique
Hemophan® was developed by introducing a positively charged substance, diethylaminoethyl
(DEAE), to RC membrane in order to improve its surface character (Membrana, Germany).
Although only a limited amount of DEAE was introduced relative to entire amount of cellulose,
complement activation was greatly suppressed. Hemophan®, however, adsorbed heparin,
which induced blood coagulation. Because of this fact, the production of this membrane was
ceased. Another trial was made by coating the membrane surface with vitamin E in order to
make the RC membrane antioxydative (Terumo, Tokyo, Japan). Later, this technique was
applied to PSf membrane and the commercial model is still available (Asahi Kasei Medical
Co., Tokyo, Japan).
6.4. Membranes with polyvinylpyrrolidone
PSf and the ones whose chemical structures are similar to PSf have the highest market share
among all dialysis membranes. They usually include polyvinylpyrrolidone (PVP) as a
hydrophilic agent since they are hydrophobic in nature. PVP was once used as a supplement
of plasma in medicine. Anaphylaxy shock, however, was reported, the cause of which was
strongly doubted to be the PVP included in the membrane. Then we performed the following
clinical investigation by using dialyzers with PSf and the ones with PEPA membrane with
different amount of PVP [11].
2nd 6th
Figure 15. Time course of C3a change during four hr treatment. The same PSf dialyzers with PVP(+++) were used in
the 1-st and last (7-th) weeks. The same FDY dialyzers with PVP(+) were used from the 2nd to the 6th weeks.
The time course of C3a concentration profile in clinical study is shown in Figure 15. PSf with
PVP(+++) showed three times higher concentration 15 minutes after the start of treatment. The
C3a elevation was slightly lower at the first use of PEPA with PVP(+) and the peak concen‐
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trations were approximately halved or even less from the second to the fifth week. The peak
concentration, however, returned back to three folds in the first use of PSf after five-week use
of PEPA with PVP(+).
According to another clinical data shown in Figure 16, PSf with PVP(+++) showed highest C3a
elevation, followed by PEPA with PVP(++), PVP(+), and PVP(-). The degree of C3a elevation
was a function of amount of PVP included in the membrane regardless of the main material
of the membrane.
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Figure 16. Time course of C3a change during four hr treatment in 1 patient. Symbols are arranged in the chronological
order from the top to the bottom.
From these results, we learned that PVP may not be the best choice as a hydrophilic agent in
terms of blood compatibility.
7. Future perspectives of dialysis membrane
With above mentioned technique, we will be able to expect an even better dialysis membrane
to come into the market. Several futuristic functions desired for dialysis membrane is also
introduced, expecting a new era to come. Followings are the problems to be solved in the future
perspectives of dialysis membrane.
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7.1. Solute removal performance
Since on-line HDF has been gaining popularity in European countries as well as in Japan, HDF
with much larger amount of fluid exchange has to be more easily performed for the further
success of this modality. Standard on-line HDF in European countries is performed in post-
dilution system with Q B=400 mL/min, Q D=700 mL/min, Q F=90 mL/min, Q S=80 mL/min=19.2
L/4hr in single patient dialysis machine (SPDM) system, whereas that in Japan is performed
in pre-dilution system with Q B=250 mL/min, Q D=500 mL/min, Q F=260 mL/min, Q S=250 mL/
min=60 L/4hr in central dialysis fluid delivery system (CDDS) [26] (Figure 17). In terms of
solute removal, the difference between these two methods is the largest target solute to be
removed, i.e., “European HDF” is targeted to remove β2-MG (MW 11,800) with little loss of
albumin (some ten mg/treatment), whereas “Japanese HDF” is targeted to remove α 1-MG
(MW 33,000) or even greater ones with albumin “removal” less than 4 g/treatment because
enough removal of α1-MG cannot be possible without removing considerable amount of
albumin (Figure 13). Although ultra-“super-high flux” dialyzers are commercially available
in Japan, termed class V in Japanese reimbursement system, which remove α1-MG to achieve
clinically effective reduction rate (> 30 %) [ 26 ], they also remove considerable amount of
albumin (> 5 g/treatment) as well as amino acids, important small solutes from the nutritional
point of view. Therefore when more precise prescriptions are necessary, on-line pre-dilution
HDF is preferred because it removes α1-MG more than 30 % with albumin loss of 4 g/treatment
or less and with considerably reduced clearance for small solutes, including amino acids, due
to reduced net dialysis fluid flow rate (net Q D=500-250=250 mL/min).
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Figure 17. Comparison of post-dilution and pre-dilution on-line HDF with typical European and Japanese flow rates,
respectively.
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According to the Italian study [17], on-line HDF/HF is a useful tool for treating patients with
dialysis induced hypotension. Then diafilters with higher hydraulic permeability with little
albumin loss that do not aim to achieve higher solute removal may be useful for those patients.
Not to mention, design specifications of dialyzer/diafilter is as important as the membrane
permeability in terms of solute removal under given therapeutic conditions.
7.2. Biocompatibility
Many classic problems with biocompatibility in the past such as transient leukopenia,
complement activation, negative charge syndrome, etc., have already been dissolved by
modifying physical and chemical structures of the dialysis membrane. Most currently
available synthetic polymeric membranes, however, employ PVP as a hydrophilic agent as
well as a pore-forming agent. Study shows that many symptoms including abrupt decrease of
blood pressure or shock right after starting treatments could be induced most probably due
to PVP included in the membrane, and it is sometimes called “PVP intolerance”. Novel
hydrophilic agents may be studied for the purpose of replacing PVP. Alternately, novel casting
technique in which no hydrophilic agent is necessary has to be studied, knowing that PMMA,
EVAL, and PEPA are cast with no additives although they are also originated from petroleum.
7.3. Surface modification and adsorption
Surface modification with the third substances is another way to obtain membranes with
preferred permeability as well as biocompatibility. For example, PSf membrane coated with
vitamin E showed a great success for reducing reactive oxygen species (ROS) as well as
free  radicals  that  also  showed  preferable  clinical  results  (Terumo,  Asahi-Kasei).  Toray
introduced a novel technique with NV polymer to their PSf membrane to reduce adsorp‐
tion  of  cells  as  well  as  protein  molecules  on  the  membrane.  Although both  two mem‐
branes work well clinically, they still utilize PVP in the same amount as previously included
before.  Then  it  should  be  noted  since  surface  modification  is  closely  related  to  solute
transport as well as biocompatibility, biomimicry situations under dialysis must be further
taken into consideration.
8. Conclusions
Since hemodialysis experiments with canines were first reported, many membranes, either
natural or synthetic polymeric ones, have been developed and the latter have been the main
stream due to higher solute and hydraulic permeabilities as well as better biocompatibility.
The mass transport mechanism across the membrane can be expressed by the Fick’s 1-st law
of diffusion; however, not only the membrane permeability but also the design specifications
are important for assembling dialyzers with better performances.
The chemical structure of the dialysis membrane determines the hydrophilicity and hydro‐
phobicity of the membrane. Since all synthetic polymeric membranes are made from petrole‐
um, they are hydrophobic in nature. Most of these membranes include a hydrophilic agent
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such as PVP for anti-thrombosis purpose. According to the in vitro experiments and clinical
observations, it was proved that PVP was closely related to the sieving coefficient for albumin
and had big influence on the complement activation. Then we must pay much attention on
additives in addition to the main material(s) of the membrane.
Physical structure of the dialysis membrane can be discussed in two ways, i.e., direct obser‐
vations by taking microscopic views (SEM) and the theoretical analysis by using a mathemat‐
ical model. There are two kind of dialysis membranes, “homogeneous” and “asymmetry”,
among which the latter is gaining popularity because of the much smaller thickness that
contributes to the resistance of solute and water transport. The pore theory is a useful tool for
analyzing mass and water transport across the membrane and for designing a physical
structure of the membrane.
Since the number of on-line hemodiafiltration (HDF) is growing these days not only from the
solute removal point of view but also from the improvement of dialysis-induced hypotension
during the treatment, membranes specifically designed for performing HDF has to be more
extensively studied both clinically and fundamentally. Importance of biocompatibility of the
membrane should be more carefully taken into account for selecting a device, considering
membrane characteristic such as adsorption, especially in the field of acute kidney injury (AKI).
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